JWCA
HAE icon

J.W. Cole Advisors’s Haemonetics HAE Stock Holding History

J.W. Cole Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+2,903
New +$186K ﹤0.01% 1466
2026
Q1 		– Sell
-2,645
Closed -$206K – 1046
2025
Q4 		$206K Buy
+2,645
New +$178K 0.01% 1292

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J.W. Cole Advisors's HAE Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in Haemonetics (HAE) in Q2 2026: 2,903 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in HAE as recently as Q4 2025.

J.W. Cole Advisors first reported a position in HAE in Q4 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • J.W. Cole Advisors held 2,903 shares of Haemonetics worth $218K as of Q2 2026.
  • Haemonetics was a new J.W. Cole Advisors position in Q2 2026.
  • Haemonetics made up ﹤0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1466 holding.
  • J.W. Cole Advisors first reported a position in Haemonetics in Q4 2025 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.